Filing Details
- Accession Number:
- 0001487371-21-000024
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-25 20:36:41
- Reporting Period:
- 2021-01-21
- Accepted Time:
- 2021-01-25 20:36:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1487371 | Genmark Diagnostics Inc. | GNMK | Surgical & Medical Instruments & Apparatus (3841) | 272053069 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1776182 | Hollis Sarah Winkler | 5964 La Place Court San Diego CA 92008 | Vp, Human Resources | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-01-21 | 10,845 | $0.00 | 135,021 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-01-21 | 16,666 | $0.00 | 151,687 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-01-25 | 10,317 | $14.22 | 141,370 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Market Stock Units | Disposition | 2021-01-21 | 10,845 | $0.00 | 10,845 | $0.00 |
Common Stock | Market Stock Units | Disposition | 2021-01-21 | 16,666 | $0.00 | 16,666 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
3,333 | No | 4 | M | Direct | ||
16,667 | No | 4 | M | Direct |
Footnotes
- The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted market stock units.
- The MSUs vest in three equal installments, on each of December 31, 2019, December 31, 2020, and December 31, 2021; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index. Based on actual performance, the Reporting Person was issued the maximum number of shares on the Issuer's two-year total Shareholder return, as compared to the Nasdaq Composite Index.
- Represents the target number of shares which remain subject to the award.
- The MSUs vest in three equal installments, on each of December 31, 2020, December 31, 2021, and December 31, 2022; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the NASDAQ Composite Index. Based on actual performance, the Reporting Person was issued the maximum number of shares on the Issuer's one-year total Shareholder return, as compared to the Nasdaq Composite Index.